Nano-inducer of ferroptosis for targeted chemotherapy of human triple negative breast carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nano-inducer of ferroptosis for targeted chemotherapy of human triple negative breast carcinoma

Published:2024-07 Issue: Volume:161 Page:213868
ISSN:2772-9508
Container-title:Biomaterials Advances
language:en
Short-container-title:Biomaterials Advances

Author:

Shetake Neena G.,Das Sourav Kumar,Kumar Amit,Pandey Badri N.

Funder

Bhabha Atomic Research Centre

Advanced Centre for Treatment, Research and Education in Cancer

Tata Institute of Fundamental Research

Department of Atomic Energy, Government of India

Publisher

Elsevier BV

Reference31 articles.

1. Current treatment landscape for early triple-negative breast cancer (TNBC);Lee;J. Clin. Med.,2023

2. Recent advances in therapeutic strategies for triple-negative breast cancer;Li;J. Hematol. Oncol.,2022

3. Conceptualizing the complexity of ferroptosis to treat triple-negative breast cancer: theory-to-practice;Zhang;Cancer Biol. Med.,2023

4. Ferroptosis and tumor immunotherapy: a promising combination therapy for tumors;Cai;Front. Oncol.,2023

5. Immunogenic cell death-relevant damage-associated molecular patterns and sensing receptors in triple-negative breast cancer molecular subtypes and implications for immunotherapy;Xu;Front. Oncol.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP